Octapharma AG: Company Profile and SWOT Analysis

Synopsis

ICD Research's Octapharma AG: Company Profile and SWOT Analysis contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.

Summary

This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.

ICD Research's Octapharma AG: Company Profile and SWOT Analysis report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.

ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope

• Examines and identifies key information and issues about Octapharma AG for business intelligence requirements
• Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported
• The profile also contains information on business operations, company history, major products and services, prospects, key competitors, key employees, locations and subsidiaries

Reasons To Buy

• Quickly enhance your understanding of the company
• Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry
• Increase business/sales activities by understanding your competitors’ businesses better
• Recognize potential partnerships and suppliers

Key Highlights

Octapharma AG (Octapharma) is engaged in the development, production and distribution of finished plasma products around the world. The company is focused on the research and development of human proteins in the fields of haematology, immunotherapy, intensive care and emergency medicine. It principally offers a variety of plasma products for the treatment of coagulation disorders and immune diseases. Besides producing plasma products, Octapharma also offers plasma based services such as supporting self-sufficiency partners and providing technology transfers through licensing. The company operates six production facilities located in Austria, France, Germany, Sweden and Mexico. In addition it operates 45 plasma donation centers in the US and Europe. Octapharma is headquartered in Lachen, Switzerland.